Related Experiment Video

Updated: Aug 18, 2026

Recapitulation of an Ion Channel IV Curve Using Frequency Components
10:14

Recapitulation of an Ion Channel IV Curve Using Frequency Components

Published on: February 8, 2011

Molecular determinants of high-affinity drug binding to HERG channels

John S Mitcheson1, Matthew D Perry

  • 1University of Leicester, Department of Cell Physiology and Pharmacology, Maurice Shock Medical Sciences Building, University Road, Leicester, LE1 9HN, UK. Jm109@le.ac.uk

Current Opinion in Drug Discovery & Development
|October 29, 2003
PubMed

Insights

Drug interactions with Human Ether-a-go-go-Related Gene (HERG) channels can cause dangerous heart rhythm problems. Understanding HERG channel drug binding is key to developing safer medications.

Area of Science:

  • Pharmacology
  • Cardiology
  • Molecular Biology

Background:

  • Human Ether-a-go-go-Related Gene (HERG) channel function is critical for cardiac action potential repolarization.
  • Inhibition of HERG currents by drugs can lead to QT interval prolongation and life-threatening arrhythmias.
  • Drug-induced QT prolongation is a significant safety concern for regulatory agencies and pharmaceutical development.

Purpose of the Study:

  • To investigate the structural basis of drug binding to HERG channels.
  • To understand the gating-dependent repositioning of residues in the HERG inner cavity.
  • To identify strategies for reducing the proarrhythmic potential of new drugs.

Main Methods:

  • Structural analysis of drug-binding sites on HERG channels.
  • Investigation of key residue movements during HERG channel gating.
  • Pharmacological profiling of compounds affecting HERG currents.

Main Results:

  • New insights into the structural mechanisms of HERG channel drug interactions.
  • Identification of specific residues involved in drug sensitivity.
  • Understanding of how channel gating influences drug binding.

Conclusions:

  • Elucidating HERG channel structure-activity relationships is crucial for drug safety.
  • Understanding drug binding and gating mechanisms can guide safer drug design.
  • This research may lead to the development of next-generation drugs with reduced cardiac risks.

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry11:32

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry

Published on: September 28, 2016

Related Concept Videos

Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...